Metaflam Oral Suspension is a liquid formulation used to treat pain and inflammation. Its active ingredient is meloxicam, a non-steroidal anti-inflammatory drug that inhibits the cyclooxygenase enzymes cox-1 and cox-2. By blocking these enzymes the drug reduces the synthesis of prostaglandins that mediate fever swelling and tissue discomfort. The resulting decrease in prostaglandin levels leads to lower body temperature and diminished inflammatory responses. Physiologically the medication influences pain signaling pathways and vascular permeability in peripheral tissues. The oral suspension provides rapid absorption into the bloodstream allowing systemic distribution to target sites. Once absorbed meloxicam competes with arachidonic acid for binding in the enzyme active site thereby limiting the production of inflammatory mediators. This combined effect produces analgesia antipyresis and reduction of swelling which together alleviate the symptoms of various painful conditions.

Metaflam Oral Suspension is a liquid formulation of meloxicam used for oral administration. Its therapeutic role is to provide anti-inflammatory and analgesic effects in patients requiring non-steroidal treatment. The drug functions primarily as a selective cox-2 inhibitor, reducing prostaglandin synthesis at inflamed sites. By attenuating prostaglandin production, it decreases inflammation, pain, and fever associated with various conditions. This mechanism operates through binding to the enzyme's active site, thereby preventing the conversion of arachidonic acid into inflammatory mediators. The resulting modulation of biochemical pathways leads to symptomatic relief of musculoskeletal and inflammatory disorders.

Metaflam Oral Suspension may cause drowsiness in some individuals. Headache is reported occasionally. Nausea can occur especially when taken on an empty stomach. Mild abdominal discomfort may be experienced. Dizziness or lightheadedness can appear temporarily. Skin reactions such as rash or itching may develop. Dry mouth is a possible side effect. In rare cases a brief allergic response may be observed.

Metaflam Oral Suspension may cause mild stomach discomfort in some users. Headache and dizziness are reported side effects that usually resolve on their own. Skin reactions such as rash or itching can occur in sensitive individuals. Nausea and occasional vomiting are possible gastrointestinal responses. Rarely, changes in blood cell counts may be observed during treatment. Temporary fatigue has been noted in a small number of patients. Mild allergic symptoms like swelling of the lips or tongue may appear. These effects are generally not severe and often diminish with continued use.